Safety of Long-Term Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label Extension Trial Up to 5 Years
Authors: Lisa A. Beck, Robert Bissonnette, Mette Deleuran, Takeshi Nakahara, Ryszard Galus, Faisal A. Khokhar, Anna Coleman, Guy Gherardi, Jing Xiao, Robert Dingman, Christine Xu, Elena Avetisova, Ariane Dubost-Brama, Arsalan Shabbir
< PREVIOUS POSTER NEXT POSTER >
